A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Buod ng balita
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Subaybayan ang mga pinakabagong balita mula sa mapagkakatiwalaang publisher na may maiikling buod. Buksan ang orihinal na link para sa detalye.